Searchable abstracts of presentations at key conferences in endocrinology

ea0056p1044 | Thyroid (non-cancer) | ECE2018

Usefulness of ultrasound evaluation of thyroid nodules in predicting malignancy

Atienza Elena , Trifu Daniela Stefania , Tasende Clara , Escribano Pablo , Saavedra Pilar , Rubio Jose Antonio , Blanco Concepcion

Introduction: Ultrasound (US) thyroid examination is the most common method to assess thyroid nodules risk of malignancy and select nodules for fine-needle aspiration biopsy (FNAB). Thyroid US evaluation performed by endocrinologists has recently increased in Spain.Objectives: To evaluate the predictive value of US features of malignancy in differentiating benign and malignant thyroid lesions in a Thyroid Nodule Clinic.Patients and...

ea0029p1667 | Thyroid (non-cancer) | ICEECE2012

Resistance to thyroid hormone: clinical, biochemical and genetic features of Mediterranean population

Amor A. , Oriola J. , Quiros C. , Alfayate R. , Borras V. , Escribano A. , Gonzalez C. , Gutierrez A. , Mauri M. , Perez P. , Pico A. , Vourliotaki I. , Halperin I.

Introduction: Resistance to thyroid hormones (RTH) is a genetic disorder caused in 85% of cases by mutations in thyroid hormone receptor beta gene (TRĪ²). The current information about it in Spanish population is scarce, limited to case reports or short series of patients. Thus, we aimed to describe the clinical, biochemical and genetic features of Mediterranean patients with RTH referred to our institution (one of the referral centres in Spain) for genetic testing during ...

ea0073aep677 | Thyroid | ECE2021

Importance in monitoring and treatment of thyroid cancer with new third-generation thyroglobulin assays

Lopez-Martos Aurora , Miguel-Angel Ruiz-Gines , Elena De-Rafael-Gonzalez , Fuentes-Bullejos Patricia , Fernando Sanchez-Escribano-Del-Palacio , Elena Valera-Nuñez , Maria-Carmen Lorenzo-Lozano , Agudo-Macazaga Mercedes

IntroductionUp by 30% of patients have recurrence in the first years after treatment of differentiated thyroid cancer (DTC) so it is necessary to have highly sensitive assays that allow adequate long-term follow-up. Nowadays, the measurement of serum thyroglobulin (Tg) is used as a tumor marker to monitoring DTC and must be determined along with levels of antithyroglobulin antibodies, since they can interfere in Tg immunoassays. Therefore, it is recommen...